NCT00576459View on ClinicalTrials.gov

Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

July 31, 2006

Conditions
Diabetic Macular Edema
Interventions
DRUG

0.59 mg fluocinolone acetonide intravitreal implant

0.59 mg

DRUG

2.1 mg fluocinolone acetonide intravitreal implant

2.1 mg

PROCEDURE

standard of care laser photocoagulation

standard of care laser photocoagulation

Trial Locations (2)

Unknown

The Chinese University of Hong Kong, Hong Kong

500 034

LV Prasad Eye Institute, Banjara Hills

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00576459 - Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema | Biotech Hunter | Biotech Hunter